- Home
- YUM vs ARGX Comparison
YUM vs ARGX Comparison
Compare YUM & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YUM
- ARGX
- Stock Information
- Founded
- YUM 1997
- ARGX 2008
- Country
- YUM United States
- ARGX Netherlands
- Employees
- YUM N/A
- ARGX N/A
- Industry
- YUM Restaurants
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YUM Consumer Discretionary
- ARGX Health Care
- Exchange
- YUM Nasdaq
- ARGX Nasdaq
- Market Cap
- YUM 37.8B
- ARGX 37.3B
- IPO Year
- YUM 1997
- ARGX 2017
- Fundamental
- Price
- YUM $128.25
- ARGX $650.39
- Analyst Decision
- YUM Hold
- ARGX Strong Buy
- Analyst Count
- YUM 17
- ARGX 20
- Target Price
- YUM $144.88
- ARGX $653.11
- AVG Volume (30 Days)
- YUM 1.8M
- ARGX 256.2K
- Earning Date
- YUM 02-06-2025
- ARGX 02-27-2025
- Dividend Yield
- YUM 2.09%
- ARGX N/A
- EPS Growth
- YUM 1.68
- ARGX N/A
- EPS
- YUM 5.35
- ARGX N/A
- Revenue
- YUM $7,223,000,000.00
- ARGX $1,908,659,000.00
- Revenue This Year
- YUM $7.53
- ARGX $70.98
- Revenue Next Year
- YUM $6.60
- ARGX $51.22
- P/E Ratio
- YUM $23.97
- ARGX N/A
- Revenue Growth
- YUM 2.32
- ARGX 85.56
- 52 Week Low
- YUM $122.13
- ARGX $349.86
- 52 Week High
- YUM $143.20
- ARGX $678.21
- Technical
- Relative Strength Index (RSI)
- YUM 45.20
- ARGX 57.29
- Support Level
- YUM $122.13
- ARGX $635.85
- Resistance Level
- YUM $127.74
- ARGX $655.52
- Average True Range (ATR)
- YUM 2.31
- ARGX 15.67
- MACD
- YUM 0.18
- ARGX -1.53
- Stochastic Oscillator
- YUM 50.59
- ARGX 54.50
About YUM Yum! Brands Inc.
Yum Brands is a US-based restaurant operator featuring a portfolio of four brands: KFC (29,900 global units at year-end 2023), Pizza Hut (19,866 units), Taco Bell (8,564 units), and The Habit Burger Grill (381 units). With $64 billion in 2023 systemwide sales, the firm is the second-largest restaurant company in the world behind McDonald's ($130 billion), ahead of Restaurant Brands International ($43 billion) and Starbucks ($29 billion). Yum is 98% franchised, with the largest franchisee, wide-moat Yum China, spun out in 2016, after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity. Yum is the newest evolution of Tricon, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.